Publicaciones

  • Francisco Javier Félix-Redondo, Luis Lozano Mera, Luciano Consuegra-Sánchez, Fernando Giménez Sáez, Francisco Javier Garcipérez de Vargas, José María Castellano Vázquez, and Daniel Fernández-Bergés. Risk factors and therapeutic coverage at 6 years in patients with previous myocardial infarction: the CASTUO study. Open HEART. 2016,3:e000368 DOI:10.1136/openhrt-2015-000368
  • Francisco Javier Félix Redondo, Luis Lozano Mera, José María Mostaza, Pedro Sáenz, Daniel Fernández Bergés, Francisco Buitrago. Control de lipoproteínas de baja densidad en población extremeña en función del sexo y del riesgo cardiovascular. Rev Esp Cardiol.2015;68:1184-6. DOI: 10.1016/j.recesp.2015. 08.006
  • Marcelino-Rodriguez I, Elosua R, Perez MD, Fernandez-Bergés D, Guembe MJ,Alonso TV, Felix FJ, Gonzalez DA, Ortiz-Marr√≥n H, Rigo F, Lapetra J, Gavrila D,Segura A, Fito M, Peñafiel J, Marrugat J, Leon AC. On the problem of type 2diabetes-related mortality in the Canary Islands, Spain. The DARIOS Study. Diabetes Res Clin Pract. 2015 Oct 23. pii: S0168-8227(15)00425-8. doi:10.1016/j.diabres.2015.10.024. [Epub ahead of print] PubMed PMID: 26546396.
  • NCD Risk Factor Collaboration (NCD-RisC). Effects of diabetes definition onglobal surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96population-based studies with 331,288 participants. Lancet Diabetes Endocrinol.2015 Aug;3(8):624-37. doi: 10.1016/S2213-8587(15)00129-1. Epub 2015 Jun 21.PubMed PMID: 26109024.
  • Robles NR, Felix FJ, Lozano L, Miranda I, Fernandez-Berges D, Macias JF. TheH.U.G.E. Formula (Hematocrit, Urea, Sex) for Screening Chronic Kidney Disease(CKD) in an Age-Stratified General Population. J Nutr Health Aging. 2015Jun;19(6):688-92. doi: 10.1007/s12603-015-0504-1. PubMed PMID: 26054506.
  • Fernández-Bergés D, Félix-Redondo FJ, Consuegra-Sánchez L, Lozano-Mera L, Miranda Díaz I, Durán Guerrero M, Benítez de Castro F, Polanco García JB, López-Mínguez JR. Infarto de miocardio en mayores de 75 años: una población en aumento. Estudio CASTUO.Rev Clin Esp. 2015 May;215(4):195-203. doi:10.1016/j.rce.2014.11.003. Epub 2014 Dec 12. English, Spanish. PubMed PMID:25499670.
  • Palomo L, Félix-Redondo FJ, Lozano Mera L, Pérez-Cstán JF, Fernández-Bergés D, Buitrago F. Cardiovascular risk factors, lifestyle , and social determinants: a cross-sectional population study. Br J Gen Pract. 2014;64:e627-33
  • Baena-Díez JM, Grau M, Forés R, Fernández-Bergés D, Elosua R, Sorribes M, Félix-Redondo FJ; Segura A, Rigo F, Cabrera de León A, Sanz H, Marrugat J, Sala J, en representación del estudio DARIOS. Prevalencia de la fibrilación auricular y sus factores de riesgo asociados. Análisis de seis estudios de base poblacional. Estudio DARIOS. Rev Clin Esp 2014;214:595-12.
  • Fernández-Bergés D, Consuegra-Sánchez L, Peñafiel J. Cabrera de León A, Vila J, Félix-Redondo FJ, Segura-Fragoso A, Lapetra J, Guembe MJ, Vega T, Fitó M, Elosua R, Díaz O, Marrugat J. Perfil inflamatorio y metabólico. Estudio DARIOS Inflamatorio. Rev Esp Cardiol 2014: 67:624-31
  • Robles NR, Felix FJ, Fernandez-Berges D, Perez-Castán J, Zaro MJ, Lozano L,Alvarez-Palacios P, Garcia-Trigo A, Tejero V, Morcillo Y, Hidalgo AB. The HUGE formula (hematocrit, urea and gender): association with cardiovascular Eur Rev Med Pharmacol Sci. 2013;17:1889-93
  • Grau M, Baena-Diez JM, Félix-Redondo FJ, Fernández-Berges D, Comas-Cuff M, Forés R, Marrugat J, Ramos R. Estimating the risk of peripheral artery Disease using different population strategies. Prev Med. 2013;57:328-33
  • Félix-Redondo FJ, Grau M, Baena-Diez JM, Degano IR, de León AC, Guembe MJ,Alzamora MT, Vega-Alonso T, Robles NR, Ortiz H, Rigo F, Mayoral-Sanchez E, Tormo MJ, Segura-Fragoso A, Fernández-Bergés D. Prevalence of obesity and associated cardiovascular risk: the DARIOS study. BMC Public Health. 2013;13:542.
  • Degano IR, Elosua R, Kaski JC, Fernández-Bergés DJ, Grau M, Marrugat J. Plaque stability and the southern European paradox. Rev Esp Cardiol. 2013;66:56-62.
  • Félix-Redondo FJ, Consuegra-Sánchez L, Ramirez-Moreno JM, Lozano L, Escudero V, Fernández-Bergés D. Ischemic stroke mortality tendency (2000-2009) and prognostic factors. ICTUS Study-Extremadura (Spain). Rev Clin Esp. 2013;213:177-85.
  • Robles NR, Felix FJ, Fernandez-Berges D, Perez-Castán J, Zaro MJ, Lozano L, Alvarez-Palacios P, Garcia-Trigo A, Tejero V, Morcillo Y, Hidalgo AB. Prevalence of abnormal urinary albumin excretion in elderly people: a Spanish survey. Int Urol Nephrol. 2013; 45:553-60.
  • Robles NR, Felix FJ, Fernandez-Berges D, Perez-Castán JF, Zaro MJ, Lozano L, Alvarez-Palacios P, Garcia-Trigo A, Tejero V, Morcillo Y, Hidalgo AB. Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population. J Nephrol. 2013; 26:675-8.
  • Félix-Redondo FJ, Grau M, Fernández-Bergés D. Cholesterol and cardiovascular disease in the elderly. Facts and gaps. Aging Dis. 2013;4:154-69.
    Robles NR, Felix FJ, Fernandez-Berges D, Perez-Castán JF, Zaro MJ, Lozano L, Alvarez-Palacios P, Garcia-Trigo A, Tejero V, Morcillo Y, Hidalgo AB. Prevalence of abnormal urinary albumin excretion in a population-based study in Spain: results from the HERMEX Study. Eur J Clin Invest. 2012;42:1272-7.
  • Fernández-Bergés D, Consuegra-Sánchez L, Félix-Redondo FJ, Robles NR, Galán Montejano M, Lozano-Mera L. [Clinical characteristics and mortality of heart failure. INCAex study.]. Rev Clin Esp. 2013; 213:16-24.
  • Félix-Redondo FJ, Fernández-Bergés D, Grau M, Baena-Diez JM, Mostaza JM, Vila J. Prevalence and clinical characteristics of peripheral arterial disease in the study population Hermex. Rev Esp Cardiol (Engl Ed). 2012;65:726-33.
  • Félix-Redondo FJ, Fernández-Bergés D, Calderón A, Consuegra-Sánchez L, Lozano L, Barrios V. Prevalence of left-ventricular hypertrophy by multiple electrocardiographic criteria in general population: Hermex study. J Hypertens.2012;30:1460-7.
  • Fernández-Bergés D, Félix-Redondo FJ, Consuegra-Sánchez L, Galán Montejano M. [Are the CHADS(2) and CHA(2)DS(2)-VASc scales useful instruments to initiate anticoagulant medication?]. Rev Clin Esp. 2012;212:418-9.
  • Félix-Redondo FJ, Baena-Díez JM, Grau M, Tormo MÁ, Fernández-Bergés D. [Prevalence of obesity and cardiovascular risk in the general population of a health area in Extremadura (Spain): the Hermex study]. Endocrinol Nutr. 2012;59:160-8.
  • Fernández-Bergés D, Cabrera de León A, Sanz H, Elosua R, Guembe MJ, Alzamora M, Vega-Alonso T, Félix-Redondo FJ, Ortiz-Marrón H, Rigo F, Lama C, Gavrila D, Segura-Fragoso A, Lozano L, Marrugat J. Metabolic syndrome in Spain: prevalence and coronary risk associated with harmonized definition and WHO proposal. DARIOS Rev Esp Cardiol (Engl Ed). 2012;65:241-8.
  • Félix-Redondo FJ, Fernández-Bergés D, Palomo Cobos L, Buitrago Ramírez F, Pérez Castán JF, Lozano Mera L. [Prevalence alcohol consumption and cardiovascular risk factors in an Extremadura health area. Hermex study]. Aten Primaria. 2012;44:201-8.
  • Daniel Fernández-Bergés, Antonio Cabrera de León, Héctor Sanz, Roberto Elosua, María J Guembe, Maite Alzamora, Tomás Vega-Alonso, Francisco J Félix-Redondo, Honorato Ortiz-Marrón, Fernando Rigo, Carmen Lama, Diana Gavrila, Antonio Segura Fragoso, Luis Lozano, Jaume Marrugat. Síndrome metabólico en España: prevalencia y riesgo coronario asociado a la definición armonizada y a la propuesta por la OMS. Estudio DARIOS. Rev Esp Cardiol 2011, en prensa.
  • Daniel Fernández-Bergés, Francisco J Félix-Redondo, Luis Lozano, José F Pérez-Castán , Héctor Sanz, Antonio Cabrera de León, Ana B Hidalgo, Yolanda Morcillo , Verónica Tejero, Paula Álvarez-Palacios. Prevalencia de síndrome metabólico en población extremeña según las nuevas recomendaciones de la OMS. Estudio HERMEX. Gac Sanitaria 2011: Jul 29. [Epub ahead of print] PMID: 21803460.
  • Fernández-Bergés D, Bertomeu-Gonzalez V, Sánchez PL, Cruz-Fernandez JM, Arroyo R, Barriales Álvarez V, Carrasco Sánchez FJ, Dalli E, Castro Beiras A, Kaski JC; SIESTA Study Investigators. Clinical scores and patient risk stratification in non-ST elevation acute coronary syndrome. Int J Cardiol. 2011;146 (2):219-24.
  • Félix-Redondo FJ, Fernández-Bergés DJ, Palomo Cobos L, Buitrago Ramirez F, Pérez-Csatán JF, Lozano Mera L. Prevalencia de consumo de alcohol según género y relación con los factores de riesgo cardiovascular en la población general extremeña. Estudio HERMEX. Aten Primaria 2011; en prensa.
  • Baena-Diez JM, Félix FJ, Grau M, Cabrera de León A, Sanz H, Leal M, Elosua R, Rodríguez-Pérez MC, Guembe MJ, Torán P, Vega-Alonso T, Ortiz H, Pérez-Castán JF, Frontera Juan G, Lapetra J, Tormo MJ, Segura A, Fernández-Bergés D, Marrugat J. Tratramiento y control de los factores de riesgo según el riesgo coronario en la población española del estudio DARIOS. Rev Esp Cardiol 2011, 64:766-73.
  • Félix-Redondo FJ, Fernández-Bergés D, Fernando Pérez J, Zaro MJ, García A, Lozano L, Sanz H, Grau M, Alvarez-Palacios P, Tejero V. [Prevalence, awareness, treatment and control of cardiovascular risk factors in the Extremadura population (Spain). HERMEX study.]. Aten Primaria. 2011 43:426-34.
  • Grau M, Elosua R, Cabrera de León A, Guembe MJ, Baena-Díez JM, Vega Alonso T, Javier Félix F, Zorrilla B, Rigo F, Lapetra J, Gavrila D, Segura A, Sanz H, Fernández-Bergés D, Fitó M, Marrugat J. [Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: the DARIOS study]. Rev Esp Cardiol 2011;64:295-304.
  • Kaski JC, Fernández-Bergés DJ, Consuegra-Sánchez L, Fernández JM, García-Moll X, Mostaza JM, Cebada RT, Juanatey JR, Martínez GG, Marrugat J. A comparative study of biomarkers for risk prediction in acute coronary syndrome-Results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study. Atherosclerosis. 2010;212:636-43.
  • Taglieri N, Fernandez-Berges DJ, Koenig W, Consuegra-Sanchez L, Fernandez JM, Robles NR, Sánchez PL, Beiras AC, Orbe PM, Kaski JC; SIESTA Investigators. Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome. Atherosclerosis. 2010;209:300-5.
  • Fernández-Bergés D, Fernández Sarabia MT, Zabala Morales MS, Félix Redondo FJ. [Cardiac hydatidic cyst]. Med Clin (Barc). 2009;132:762-3.
  • Félix-Redondo FJ, Fernández-Bergés D, Ríos-Rivera J, Pérez-Castán JF, Valiente-Rubio JI, Molina-Martínez LM. [Blood pressure control in a hypertensive population when measurements are performed in the clinic or self-monitoring by the patient]. Aten Primaria. 2009;4:120-2.
  • Félix-Redondo FJ, Fernández-Bergés D, Espinosa-Garcia J, Pozuelos-Estrada J, Molina-Martínez LM, Pérez-Castán JF, Ríos-Rivera J, Valiente-Rubio JI, Gómez-de-la-Cámara A, Rodríguez-Pascual N. Level of blood pressure control in a hypertensive population when measurements are performed outside the clinical setting. Cardiol J. 2009;16:57-67.
  • Kaski JC, Consuegra-Sanchez L, Fernandez-Berges DJ, Cruz-Fernandez JM, Garcia-Moll X, Marrugat J, Mostaza J, Toro-Cebada R, González-Juanatey JR, Guzmán-Martínez G; SIESTA Investigators. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis. 2008;201:176-83.
  • Kaski JC, Fernandez-Berges D. Secondary prevention after acute myocardial infarction and coronary revascularisation: focus on Angiotensin converting enzyme inhibitors. Cardiovasc Drugs Ther. 2008;22 (3):185-91. Review.
  • Kaski JC, Fernández-Bergés D. [C-reactive protein in the emergency department: has it found a clinical application?]. Rev Esp Cardiol. 2007;60:797-800.

Deja un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *